NBY 財務： NovaBay Pharmaceuticals Inc AI 分析

Q: 技術分析指標如何適用於 NBY？

根據技術分析，NovaBay Pharmaceuticals Inc 的綜合信號為 Strong Buy。NovaBay Pharmaceuticals Inc 有 5 個買入信號，2 個中性信號和 0 個賣出信號。

Q: NBY 的費波那契回檔水準是多少？

NovaBay Pharmaceuticals Inc 的費波那契回檔水準是 介於 61.8% 和 78.6% 之間。

Q: NovaBay Pharmaceuticals Inc 的 RSI 是多少？

NovaBay Pharmaceuticals Inc 的 RSI 目前為 66.84，表明處於 中立 狀態

Q: NovaBay Pharmaceuticals Inc 接下來 12 個月的價格是多少？

NovaBay Pharmaceuticals Inc NBY 接下來 12 個月的價格預估為 $0.867。

Q: NovaBay Pharmaceuticals Inc 預計會漲到多高？

據華爾街分析師稱，NovaBay Pharmaceuticals Inc 預計將達到 $0.8925 的高預測值。

首頁

股票

NBY

預測

NBY 股票價格預測

NovaBay Pharmaceuticals Inc

$14.77

16.39%

$2.08

收盤價：Jan 16, 16:00:00 GMT-5

$12.91

-12.59%

$-1.85

盤後：Jan 16, 20:00:00 GMT-5

概觀預測收益股利財務狀況

關鍵數據

前收市價

$12.69

開盤價

$12.3

當日範圍

$11.91 - $18.4

52週區間

$0.46 - $19.95

交易量

2.7M

平均成交量

1.2M

每股盈餘 (TTM)

-6.62

股息收益率

市值

$1.6B

什麼是 NBY？

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.

功能特性

交易策略

資源

市場

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for NBY in the upcoming periods. Looking toward the future, our 2026 projection indicates an average price target of $0.867. The lowest target is $0.8584 and the highest is $0.8925. Empower your investment choices with our cutting-edge, data-driven analysis!

NBY 股價預測摘要

NBY 的頂級分析師評級

根據 5 位分析師對 NBY 的股票評級，更新於 Aug 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for NBY. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: NBY is a Buy candidate.

NBY stock price ended at $14.77 on 星期五, after rising 16.39%

On the latest trading day Jan 16, 2026, the stock price of NBY rose by 16.39%, climbing from $12.30 to $14.77. During the session, the stock saw a volatility of 57.00%, with prices oscillating between a daily low of $11.72 and a high of $18.40. Notably, trading volume dropped by 1.7M shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 2.7M shares were traded, equating to a market value of approximately $1.8B.

NBY 技術面訊號

技術面訊號摘要

購買訊號 5

中性訊號 2

賣出訊號 0

Strong Sell

Sell

Neutral

Buy

Strong Buy

NBY 目前顯示 5 個買入訊號與 0 個賣出訊號。該股票自 12:00 AM 以來一直處於上升趨勢狀態，在此期間價格總共變動了 16.39%。整體而言，技術指標顯示中期後市趨勢為 Strong Buy。

NBY 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為NBY生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 NBY？



NBY 的費波那契回檔水準是多少？



NovaBay Pharmaceuticals Inc 的 RSI 是多少？



NovaBay Pharmaceuticals Inc 接下來 12 個月的價格是多少？



NovaBay Pharmaceuticals Inc 預計會漲到多高？



NovaBay Pharmaceuticals Inc（NBY）價格

NBY 股價走勢圖